Diabetes Defense

Enzymotec Ltd.'s carDiabeat line is designed specially to fight the major risks for cardiovascular disorders of diabetes patients. The line simultaneously tackles the three major causes for cardiovascular diseases: prevention and control of oxidative stress, reduction of total cholesterol and triglyceride levels, and inhibition of the atherosclerotic plaque formation cascade. carDiabeat is based on a clinically proven and proprietary combination of enzymatically derived natural lipids, including DHA and EPA, in a unique delivery system that enhances their efficacy and bioavailability. Enzymotec, Sharon Maraton, +972-4-6545112, sharon@enzymotec.com

Looking for a reprint of this article?
From high-res PDFs to custom plaques, order your copy today!

Switching from plastic to paper-based packaging often comes with new challenges. This webinar will explore how an ovenable, fiber-based packaging solution can deliver the benefits of plastic with 90% less plastic usage.

The Winter Fancy Food Show is where specialty food makers go to exhibit their newest and best products and where buyers go to find their next bestsellers.